SEC Form 4 · accession 0001805099-26-000008
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip P Boudreau
Officer — EVP AND CFO
Period of report
Sep 1, 2026
Accepted (ET)
Sep 3, 2026 · 6:02 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Sep 1, 2026 | F | 388 | $110.36 | D | 70,784 | D | |
| Common shares without par valueF1 | holding | — | — | — | 9,332 | I | Profit Sharing Trust | |
| Common shares without par value | holding | — | — | — | 2,200 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of September 1, 2026.